Roche has gained FDA approval for the new HIV viral load test, the COBAS TaqMan HIV-1 Test, v2.0, and will launch the product in the US, later in 2012. The COBAS TaqMan HIV-1 Test, v2.0, targets two highly conserved regions of the HIV-1 ...
Roche has entered into a collaboration agreement to integrate Elsevier's Reaxys workflow solution into its propriety reaction information to improve productivity and benefit from increased discoverability of in-house chemistry content as ...
Tags: Roche, Reaxys workflow solution, integrated chemistry data
Ventana Medical Systems, a member of the Roche Group, has introduced a fully-automated staining technique, which helps researchers to examine miRNAs and proteins related to cancer in the same section of tumor tissue. Detecting miRNAs and ...
Tags: Ventana Medical Systems, miRNAs, proteins related to cancer
Mylan has announced the launch of Ibandronic Acid Film Coated Tablets POM, 150mg, to treat osteoporosis in the UK and Italy. The product, launched by Mylan's subsidiaries based in the UK and Italy, is the generic version of Roche's ...
Tags: Mylan, ibandronic acid, ibandronic acid film coated tablets POM
Curis, a drug development company, has reported a net loss of $3.38m, or $0.04 per share, for the third quarter ended 30 September 2012 compared to a net loss of $4.21m, or $0.05 per share, for the third quarter ended 30 September 2011. ...
Tags: Net Loss, proprietary and licensed programs, clinical trial
Advanced Explorations Inc announced that encouraging results from the recently completed 2012 drill campaign at its Tuktu 2 Iron Project located 60 km north of the Roche Bay Iron Project on the Melville Peninsula in Nunavut, Canada. ...
Tags: iron project, advanced explorations, Tuktu
Teva UK, a part of Teva Pharmaceutical Industries, has announced the launch of generic Ibandronic Acid 150mg film-coated tablets. Ibandronic Acid is a generic version of Bonviva (Ibandronic Acid) from Roche. The product is indicated for ...
Tags: Generic Bonviva, Ibandronic Acid, treatment of osteoporosis
Roche has launched a new FDA-approved dual-target HIV-1 viral load test to improve the ability of physicians to monitor viral load and manage the treatment of people living with human immunodeficiency virus (HIV). The COBAS TaqMan HIV-1 ...
Tags: Viral Load Test, Dual-target HIV-1 Viral Load Test, Roche
Don Stookey knew he had botched the experiment.One day in 1952,the Corning Glass Works chemist placed a sample of photosensitive glass inside a furnace and set the temperature to 600 degrees Celsius.At some point during the run,a faulty ...
Tags: glass works, Corning, pyroceram, construction
Affymetrix and PathGEN Dx have entered into an agreement for the development of an in-vitro diagnostic kit for pathogen detection. Under the agreement, PathGEN Dx will use its PathGEN PathChip for the development of the kit, designed to ...
Tags: in-vitro diagnostic kit, kit for pathogen detection, samples
Genentech, a member of Roche Group, has obtained clearance for its Lucentis 0.3 mg (ranibizumab injection) from the US Food and Drug Administration (FDA). Lucentis 0.3 mg is a recombinant humanized monoclonal antibody fragment (lacking an ...
Tags: Genentech, Lucentis 0.3 mg, Medicine, Injection
The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Roche's new fully automated COBAS AmpliPrep / COBAS TaqMan CMV test to quantify cytomegalovirus' (CMV) DNA in human plasma specimens. The real-time ...
Tags: Roche, FDA, Viral Load Test, PCR-based CMV test
Roche, a global health-care company, has introduced new cobas p 312 pre-analytical system in the US and Canada. The cobas pre-analytical system is a front-end automation solution that provides comprehensive, vendor-neutral sample ...
Tags: Roche, pre-analytical system, cobas p 312 pre-analytical system
Roche has submitted TnT-hs assay's 510(k) application to the US Food and Drug Administration (FDA) for use on its cobas immunoassay and Elecsys analyzers. The TnT-hs is an electrochemiluminescence immunoassay designed for in-vitro ...
Tags: FDA, Roche, TnT-hs assay, analyzers
Astellas Pharma has announced favorable US court ruling in patent infringement case for OSI Pharmaceuticals, Genentech, a member of the Roche Group, and Pfizer. The US District Court for the District of Delaware has found both the patents ...
Tags: Astellas Pharma, Mylan, lawsuit